Preclinical development of a new kinase inhibitor for postviral lung disease

Ended Project Grant Awarded Last action

Award ID
W81XWH2210281
Recipient
Awarding agency
Obligated
$2,580,154

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
University City, MO 63130, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Original award $2,580,154

Subawards

Subrecipient Amount Awarded
Nupeak Therapeutics Inc. NuPeak description and SOW The NuPeak subcontract site will be responsible for oversight of all contract research organization activities in the project. This… $199,128
University Of Texas Medical Branch At Galveston UTMB description and SOW The UTMB subcontract site will conduct the proposed BSL-3 studies in our hamster model of Covid-19. These studies are budgeted for 2… $0
Nupeak Therapeutics Inc. NuPeak description and SOW The NuPeak subcontract site will be responsible for oversight of all contract research organization activities in the project. This… $551,009
University Of Texas Medical Branch At Galveston UTMB description and SOW The UTMB subcontract site will conduct the proposed BSL-3 studies in our hamster model of Covid-19. These studies are budgeted for 2… $97,110

Quick answers

Who received award W81XWH2210281?

W81XWH2210281 was awarded to The Washington University by Defense Health Agency (Department of Defense) on July 1, 2022.

How much is award W81XWH2210281 worth?

$2,580,154 has been obligated on W81XWH2210281.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login